DMD and Duchenne muscular dystrophy: To evaluate whether these SSOs modulate the splicing of endogenous human dystrophin pre-mRNA, we used myogenic cells derived from a DMD patient carrying a deletion of exons 48–50 that would be frame-corrected by skipping exon 51 [32].